подгрупи пациенти (инфектираните с генотип 1 и тези с висок вирусен товар) (Таблица 3). в
The relative benefit of combination therapy with Viraferon + ribavirin is particularly significant in the most difficult to treat subgroup of patients (genotype 1 and high virus load) (Table 3).